Paper41218342
Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer.
Di Giosaffatte N and 38 others. Breast, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer. Papers, record 41218342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41218342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Subtype distribution, clinical presentation, and molecular spectrum of neurofibromatosis type 1-associated breast cancer.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Neurofibromatosis 1 | Major topic |
| Neurofibromin 1 | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Adult | |
| Aged | |
| Mutation, Missense | |
| Age of Onset | |
| Erb-b2 Receptor Tyrosine Kinases |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33673681 | Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of NF1 Variants. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33673681 | PubMed |
| 2 | 33114250 | Nuclear Isoforms of Neurofibromin Are Required for Proper Spindle Organization and Chromosome Segregation. | Cells | 2020 | https://conductscience.org/library/papers/33114250 | PubMed |
| 3 | 21694737 | Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. | Eur J Hum Genet | 2011 | https://conductscience.org/library/papers/21694737 | PubMed |
| 4 | 21621223 | Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. | J Pediatr | 2011 | https://conductscience.org/library/papers/21621223 | PubMed |
| 5 | 30190611 | Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. | Genet Med | 2019 | https://conductscience.org/library/papers/30190611 | PubMed |
| 6 | 30530636 | Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation. | J Med Genet | 2019 | https://conductscience.org/library/papers/30530636 | PubMed |
| 7 | 26432421 | Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1. | Cancer Med | 2015 | https://conductscience.org/library/papers/26432421 | PubMed |
| 8 | 31495828 | Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study. | Genet Med | 2020 | https://conductscience.org/library/papers/31495828 | PubMed |
| 9 | 29290338 | Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848. | Am J Hum Genet | 2018 | https://conductscience.org/library/papers/29290338 | PubMed |
| 10 | 34012067 | Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. | Genet Med | 2021 | https://conductscience.org/library/papers/34012067 | PubMed |
| 11 | 35084436 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. | JAMA Oncol | 2022 | https://conductscience.org/library/papers/35084436 | PubMed |
| 12 | 34707296 | The structure of neurofibromin isoform 2 reveals different functional states. | Nature | 2021 | https://conductscience.org/library/papers/34707296 | PubMed |
| 13 | 18720457 | Refinement of breast cancer classification by molecular characterization of histological special types. | J Pathol | 2008 | https://conductscience.org/library/papers/18720457 | PubMed |
| 14 | 34535841 | Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions. | Hum Genet | 2021 | https://conductscience.org/library/papers/34535841 | PubMed |
| 15 | 18546366 | Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. | Hum Mutat | 2008 | https://conductscience.org/library/papers/18546366 | PubMed |
| 16 | 20082463 | Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. | Am J Med Genet A | 2010 | https://conductscience.org/library/papers/20082463 | PubMed |
| 17 | 37081086 | The therapeutic potential of neurofibromin signaling pathways and binding partners. | Commun Biol | 2023 | https://conductscience.org/library/papers/37081086 | PubMed |
| 18 | 38154814 | Breast cancer risk in NF1-deleted patients. | J Med Genet | 2024 | https://conductscience.org/library/papers/38154814 | PubMed |
| 19 | 23165953 | Increased risk of breast cancer in women with NF1. | Am J Med Genet A | 2012 | https://conductscience.org/library/papers/23165953 | PubMed |
| 20 | 28891274 | Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer. | Genes Chromosomes Cancer | 2018 | https://conductscience.org/library/papers/28891274 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| NF1 | 4763 | PubTator's text mining | https://conductscience.org/library/genes/4763 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41218342
GET https://conductscience.org/api/papers/v1/41218342/authors?page=2